68 results
Page 2 of 4
8-K
EX-99.1
8ep4jcvs0dd87byy2ou2
3 May 21
Karyopharm Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress
7:20am
8-K
EX-10.4
yiumy16tnl
31 Aug 20
Departure of Directors or Certain Officers
4:36pm
424B5
tnohqmqyg7h111h
5 May 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
kdb5vo p5
4 Mar 20
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
4:22pm
424B5
lsi0a
4 Mar 20
Prospectus supplement for primary offering
4:15pm
424B5
rbmw8qypb47nvzvk
2 Mar 20
Prospectus supplement for primary offering
4:21pm
S-3ASR
pk9wli
26 Feb 20
Automatic shelf registration
8:35am
424B5
vtam34
10 May 19
Prospectus supplement for primary offering
4:16pm
8-K
EX-99.1
6hkdi00evnyl
9 May 19
Results of Operations and Financial Condition
7:10am